Organon & Co. (OGN)
13.79
-0.04
(-0.29%)
USD |
NYSE |
Nov 05, 16:00
13.79
0.00 (0.00%)
Pre-Market: 20:00
Organon Net Income (TTM) : 213.00M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 213.00M |
| June 30, 2026 | 209.00M |
| March 31, 2026 | 246.00M |
| December 31, 2025 | 187.00M |
| September 30, 2025 | 501.00M |
| June 30, 2025 | 700.00M |
| March 31, 2025 | 750.00M |
| December 31, 2024 | 864.00M |
| September 30, 2024 | 1.301B |
| June 30, 2024 | 1.00B |
| March 31, 2024 | 1.047B |
| December 31, 2023 | 1.023B |
| Date | Value |
|---|---|
| September 30, 2023 | 585.00M |
| June 30, 2023 | 754.00M |
| March 31, 2023 | 746.00M |
| December 31, 2022 | 917.00M |
| September 30, 2022 | 1.011B |
| June 30, 2022 | 1.107B |
| March 31, 2022 | 1.304B |
| December 31, 2021 | 1.351B |
| September 30, 2021 | 1.525B |
| June 30, 2021 | 1.762B |
| March 31, 2021 | 1.917B |
| December 31, 2020 | 2.256B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Viatris, Inc. | -- |
| Pacira Biosciences, Inc. | 14.64M |
| Bristol Myers Squibb Co. | 9.242B |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 159.33M |